| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | primary miRNA binding | 5.37e-07 | 10 | 34 | 3 | GO:0070878 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.41e-04 | 694 | 34 | 7 | GO:0003729 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.14e-04 | 78 | 34 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.39e-04 | 80 | 34 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 8.91e-04 | 26 | 34 | 2 | GO:0070412 | |
| GeneOntologyMolecularFunction | helicase activity | 2.43e-03 | 158 | 34 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.46e-03 | 562 | 34 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 4.43e-03 | 645 | 34 | 5 | GO:0140640 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 5.30e-03 | 417 | 34 | 4 | GO:0140098 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 5.31e-03 | 64 | 34 | 2 | GO:0036002 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 6.20e-08 | 129 | 34 | 6 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.07e-07 | 158 | 34 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.01e-06 | 207 | 34 | 6 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.61e-06 | 358 | 34 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.61e-06 | 358 | 34 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.73e-06 | 362 | 34 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | primary miRNA processing | 4.58e-06 | 20 | 34 | 3 | GO:0031053 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 6.55e-06 | 443 | 34 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.30e-05 | 28 | 34 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.45e-05 | 29 | 34 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.48e-05 | 502 | 34 | 7 | GO:0008380 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.16e-05 | 33 | 34 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | mRNA processing | 2.69e-05 | 551 | 34 | 7 | GO:0006397 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 5.17e-05 | 44 | 34 | 3 | GO:0048026 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CRY2 PPHLN1 TIMELESS PPP1R13L SPEN BCLAF1 DDX5 YLPM1 ZKSCAN3 NCOA5 | 5.81e-05 | 1399 | 34 | 10 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CRY2 PPHLN1 TIMELESS PPP1R13L SPEN BCLAF1 DDX5 YLPM1 ZKSCAN3 NCOA5 | 6.32e-05 | 1413 | 34 | 10 | GO:1902679 |
| GeneOntologyBiologicalProcess | miRNA processing | 6.73e-05 | 48 | 34 | 3 | GO:0035196 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 7.16e-05 | 49 | 34 | 3 | GO:0050685 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 8.56e-05 | 52 | 34 | 3 | GO:0006376 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 9.58e-05 | 917 | 34 | 8 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.25e-04 | 59 | 34 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.52e-04 | 63 | 34 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 2.45e-04 | 74 | 34 | 3 | GO:0070918 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.49e-04 | 1053 | 34 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.97e-04 | 79 | 34 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 4.50e-04 | 91 | 34 | 3 | GO:0006446 | |
| GeneOntologyBiologicalProcess | RNA processing | 5.51e-04 | 1500 | 34 | 9 | GO:0006396 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 5.76e-04 | 99 | 34 | 3 | GO:0000245 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 7.79e-04 | 254 | 34 | 4 | GO:0071826 | |
| GeneOntologyBiologicalProcess | DNA damage response | 8.21e-04 | 959 | 34 | 7 | GO:0006974 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 8.38e-04 | 259 | 34 | 4 | GO:1903313 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 8.91e-04 | 115 | 34 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | translational initiation | 1.33e-03 | 132 | 34 | 3 | GO:0006413 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.46e-03 | 515 | 34 | 5 | GO:0022613 | |
| GeneOntologyBiologicalProcess | regulation of hippo signaling | 1.88e-03 | 39 | 34 | 2 | GO:0035330 | |
| GeneOntologyCellularComponent | nuclear speck | 3.47e-07 | 431 | 34 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 1.54e-05 | 4 | 34 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.40e-05 | 215 | 34 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CRY2 TFIP11 POLR2M TIMELESS RBMXL2 RBMXL1 DROSHA BCLAF1 RBMX DDX5 | 4.53e-05 | 1377 | 34 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | 7.84e-05 | 903 | 34 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 5.22e-04 | 97 | 34 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | pole plasm | 1.01e-03 | 29 | 34 | 2 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 1.01e-03 | 29 | 34 | 2 | GO:0060293 | |
| GeneOntologyCellularComponent | P granule | 1.01e-03 | 29 | 34 | 2 | GO:0043186 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 2.69e-03 | 1194 | 34 | 7 | GO:1990904 | |
| Domain | RRM_1 | 8.01e-08 | 208 | 34 | 7 | PF00076 | |
| Domain | RRM | 1.07e-07 | 217 | 34 | 7 | SM00360 | |
| Domain | RRM_dom | 1.45e-07 | 227 | 34 | 7 | IPR000504 | |
| Domain | RRM | 1.59e-07 | 230 | 34 | 7 | PS50102 | |
| Domain | - | 2.37e-07 | 244 | 34 | 7 | 3.30.70.330 | |
| Domain | RBM1CTR | 3.07e-07 | 8 | 34 | 3 | PF08081 | |
| Domain | RBM1CTR | 3.07e-07 | 8 | 34 | 3 | IPR012604 | |
| Domain | Nucleotide-bd_a/b_plait | 3.46e-07 | 258 | 34 | 7 | IPR012677 | |
| Domain | RRM_dom_euk | 9.52e-06 | 23 | 34 | 3 | IPR003954 | |
| Domain | RRM_1 | 9.52e-06 | 23 | 34 | 3 | SM00361 | |
| Domain | DEAD_ATP_HELICASE | 2.39e-05 | 31 | 34 | 3 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 2.90e-05 | 33 | 34 | 3 | IPR000629 | |
| Domain | RNA_helicase_DEAD_Q_motif | 4.11e-05 | 37 | 34 | 3 | IPR014014 | |
| Domain | Q_MOTIF | 4.11e-05 | 37 | 34 | 3 | PS51195 | |
| Domain | DEAD | 3.14e-04 | 73 | 34 | 3 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.14e-04 | 73 | 34 | 3 | IPR011545 | |
| Domain | Helicase_C | 9.61e-04 | 107 | 34 | 3 | PF00271 | |
| Domain | HELICc | 9.61e-04 | 107 | 34 | 3 | SM00490 | |
| Domain | Helicase_C | 9.88e-04 | 108 | 34 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 1.01e-03 | 109 | 34 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.01e-03 | 109 | 34 | 3 | PS51192 | |
| Domain | DEXDc | 1.01e-03 | 109 | 34 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.04e-03 | 110 | 34 | 3 | IPR014001 | |
| Pathway | WP_MRNA_PROCESSING | 1.30e-07 | 451 | 28 | 9 | MM15946 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.21e-05 | 23 | 28 | 3 | M41817 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.57e-05 | 25 | 28 | 3 | MM15608 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 4.40e-05 | 35 | 28 | 3 | M41738 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 5.21e-05 | 37 | 28 | 3 | MM15683 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.44e-05 | 212 | 28 | 5 | M14033 | |
| Pathway | KEGG_SPLICEOSOME | 1.09e-04 | 127 | 28 | 4 | M2044 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.12e-04 | 283 | 28 | 5 | M13087 | |
| Pathway | PID_CIRCADIAN_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M95 | |
| Pathway | WP_MRNA_PROCESSING | 1.94e-03 | 126 | 28 | 3 | M39406 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.56e-03 | 724 | 28 | 6 | M16843 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GIGYF2 TFIP11 TIMELESS SRSF10 RBMXL2 SRSF6 SPEN USP42 RBBP6 BCLAF1 RBMX EIF4B YLPM1 SMTN | 6.00e-15 | 774 | 34 | 14 | 15302935 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | GIGYF2 PPHLN1 SRSF10 SRSF6 SPEN RBBP6 DROSHA BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 NCOA5 | 1.06e-14 | 807 | 34 | 14 | 22681889 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX3Y TFIP11 SRSF10 SRSF6 RBMXL1 SPEN USP42 RBBP6 DROSHA BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 2.40e-14 | 1082 | 34 | 15 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | GIGYF2 DDX3Y PPHLN1 TFIP11 SRSF10 SRSF6 SPEN RBBP6 BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 | 1.04e-13 | 954 | 34 | 14 | 36373674 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ADAMTS18 PPHLN1 SRSF6 PPP1R13L SPEN RBBP6 BCLAF1 RBMX DDX3X EIF4B | 1.35e-12 | 361 | 34 | 10 | 26167880 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PPHLN1 TFIP11 SRSF10 SRSF6 ZBTB11 USP42 BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 NCOA5 | 3.93e-12 | 989 | 34 | 13 | 36424410 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PPHLN1 SRSF10 SRSF6 PPP1R13L RBMXL1 SPEN RBBP6 MARK3 BCLAF1 RBMX DDX3X EIF4B DDX5 NCOA5 | 4.28e-12 | 1257 | 34 | 14 | 36526897 |
| Pubmed | GIGYF2 PPHLN1 TFIP11 SRSF10 SRSF6 RBBP6 DROSHA BCLAF1 RBMX DDX3X DDX5 NCOA5 | 1.35e-11 | 847 | 34 | 12 | 35850772 | |
| Pubmed | PPHLN1 TFIP11 SRSF10 SRSF6 RBMXL1 SPEN RBBP6 BCLAF1 RBMX DDX5 NCOA5 | 6.05e-11 | 731 | 34 | 11 | 29298432 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PPHLN1 TFIP11 SRSF10 SRSF6 SPEN USP42 RBBP6 BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 1.10e-10 | 1294 | 34 | 13 | 30804502 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.26e-10 | 258 | 34 | 8 | 37794589 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | GIGYF2 TFIP11 SRSF6 PPP1R13L RBBP6 BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 | 7.02e-10 | 922 | 34 | 11 | 27609421 |
| Pubmed | PPHLN1 TFIP11 SRSF10 SRSF6 RBMXL1 RBBP6 BCLAF1 RBMX DDX3X DDX5 | 1.04e-09 | 713 | 34 | 10 | 29802200 | |
| Pubmed | 3.51e-09 | 244 | 34 | 7 | 29884807 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.89e-09 | 605 | 34 | 9 | 28977666 | |
| Pubmed | 5.95e-09 | 421 | 34 | 8 | 34650049 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 8144024 | ||
| Pubmed | 9.72e-09 | 655 | 34 | 9 | 35819319 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.78e-09 | 283 | 34 | 7 | 30585729 | |
| Pubmed | 1.05e-08 | 286 | 34 | 7 | 32041737 | ||
| Pubmed | 1.08e-08 | 75 | 34 | 5 | 31527668 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.31e-08 | 678 | 34 | 9 | 30209976 | |
| Pubmed | 1.50e-08 | 80 | 34 | 5 | 25662211 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.50e-08 | 170 | 34 | 6 | 16159877 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.58e-08 | 949 | 34 | 10 | 36574265 | |
| Pubmed | DDX3Y TFIP11 SRSF10 SRSF6 RBBP6 MARK3 BCLAF1 RBMX DDX3X EIF4B DDX5 | 1.61e-08 | 1247 | 34 | 11 | 27684187 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.04e-08 | 714 | 34 | 9 | 28302793 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.23e-08 | 1024 | 34 | 10 | 24711643 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CRY2 GIGYF2 POLR2M SRSF6 PPP1R13L DROSHA BCLAF1 DDX3X EIF4B DDX5 | 3.67e-08 | 1038 | 34 | 10 | 26673895 |
| Pubmed | 3.95e-08 | 347 | 34 | 7 | 16033648 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 4.44e-08 | 353 | 34 | 7 | 27545878 | |
| Pubmed | 7.13e-08 | 109 | 34 | 5 | 29511296 | ||
| Pubmed | 7.52e-08 | 223 | 34 | 6 | 20020773 | ||
| Pubmed | 8.17e-08 | 112 | 34 | 5 | 28416769 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CRY2 TFIP11 TIMELESS SRSF6 BCLAF1 RBMX EIF4B DDX5 YLPM1 SMTN | 9.95e-08 | 1155 | 34 | 10 | 20360068 |
| Pubmed | 1.11e-07 | 615 | 34 | 8 | 31048545 | ||
| Pubmed | 1.28e-07 | 244 | 34 | 6 | 30349055 | ||
| Pubmed | 1.31e-07 | 245 | 34 | 6 | 21182205 | ||
| Pubmed | 1.51e-07 | 251 | 34 | 6 | 28077445 | ||
| Pubmed | 1.51e-07 | 251 | 34 | 6 | 31076518 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.70e-07 | 256 | 34 | 6 | 32698014 | |
| Pubmed | 1.87e-07 | 12 | 34 | 3 | 26041499 | ||
| Pubmed | 2.32e-07 | 138 | 34 | 5 | 30320910 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 2.80e-07 | 695 | 34 | 8 | 23602568 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 2.90e-07 | 57 | 34 | 4 | 14559993 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 3.40e-07 | 149 | 34 | 5 | 26370502 | |
| Pubmed | 3.78e-07 | 723 | 34 | 8 | 34133714 | ||
| Pubmed | 3.87e-07 | 153 | 34 | 5 | 28225217 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 4.00e-07 | 154 | 34 | 5 | 16055720 | |
| Pubmed | DDX3Y PPHLN1 TFIP11 SRSF10 ARHGEF40 MARK3 DROSHA BCLAF1 RBMX YLPM1 | 4.84e-07 | 1371 | 34 | 10 | 36244648 | |
| Pubmed | 4.87e-07 | 503 | 34 | 7 | 16964243 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 5.30e-07 | 163 | 34 | 5 | 22113938 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 6.34e-07 | 169 | 34 | 5 | 23084401 | |
| Pubmed | 7.50e-07 | 330 | 34 | 6 | 32529326 | ||
| Pubmed | SRSF10 RBMXL2 ZBTB11 RBMXL1 SPEN BCLAF1 RBMX EIF4B DDX5 YLPM1 | 7.67e-07 | 1442 | 34 | 10 | 35575683 | |
| Pubmed | 8.95e-07 | 551 | 34 | 7 | 34728620 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30613052 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34437837 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11591417 | ||
| Pubmed | Structural characterization and expression studies of Dby and its homologs in the mouse. | 9.28e-07 | 2 | 34 | 2 | 16728723 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21327109 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35588748 | ||
| Pubmed | Gene structure of the human DDX3 and chromosome mapping of its related sequences. | 9.28e-07 | 2 | 34 | 2 | 11710523 | |
| Pubmed | BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells. | 9.28e-07 | 2 | 34 | 2 | 25091051 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.64e-07 | 184 | 34 | 5 | 32908313 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.26e-06 | 361 | 34 | 6 | 30344098 | |
| Pubmed | 1.30e-06 | 22 | 34 | 3 | 37298108 | ||
| Pubmed | 1.46e-06 | 85 | 34 | 4 | 29228324 | ||
| Pubmed | 1.64e-06 | 205 | 34 | 5 | 28927264 | ||
| Pubmed | 2.32e-06 | 220 | 34 | 5 | 24550385 | ||
| Pubmed | The dynamic interactome of human Aha1 upon Y223 phosphorylation. | 2.37e-06 | 96 | 34 | 4 | 26693507 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.56e-06 | 934 | 34 | 8 | 33916271 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.63e-06 | 410 | 34 | 6 | 26949251 | |
| Pubmed | 2.68e-06 | 650 | 34 | 7 | 38777146 | ||
| Pubmed | 2.73e-06 | 652 | 34 | 7 | 31180492 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23482664 | ||
| Pubmed | RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene. | 2.78e-06 | 3 | 34 | 2 | 10391207 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 34458856 | ||
| Pubmed | RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. | 2.78e-06 | 3 | 34 | 2 | 17188681 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 24219989 | ||
| Pubmed | 2.96e-06 | 660 | 34 | 7 | 32780723 | ||
| Pubmed | 3.24e-06 | 425 | 34 | 6 | 21081503 | ||
| Pubmed | 3.27e-06 | 236 | 34 | 5 | 36339263 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 3.46e-06 | 430 | 34 | 6 | 38172120 | |
| Pubmed | 3.48e-06 | 239 | 34 | 5 | 26641092 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 3.49e-06 | 1318 | 34 | 9 | 30463901 | |
| Pubmed | 3.92e-06 | 245 | 34 | 5 | 35652658 | ||
| Pubmed | 4.00e-06 | 441 | 34 | 6 | 31239290 | ||
| Pubmed | 5.24e-06 | 260 | 34 | 5 | 36199071 | ||
| Pubmed | SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene. | 5.56e-06 | 4 | 34 | 2 | 19403048 | |
| Pubmed | Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8. | 5.56e-06 | 4 | 34 | 2 | 22222205 | |
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 25963660 | ||
| Pubmed | Coupling of human circadian and cell cycles by the timeless protein. | 5.56e-06 | 4 | 34 | 2 | 15798197 | |
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 19626115 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 6.26e-06 | 477 | 34 | 6 | 31300519 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 6.58e-06 | 1425 | 34 | 9 | 30948266 | |
| Pubmed | 6.75e-06 | 274 | 34 | 5 | 34244482 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 6.97e-06 | 486 | 34 | 6 | 30940648 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 7.38e-06 | 759 | 34 | 7 | 35915203 | |
| Pubmed | 7.66e-06 | 1084 | 34 | 8 | 11544199 | ||
| Interaction | SRPK2 interactions | ADAMTS18 PPHLN1 TFIP11 SRSF10 SRSF6 PPP1R13L SPEN RBBP6 DROSHA BCLAF1 RBMX DDX3X EIF4B DDX5 | 3.31e-12 | 717 | 34 | 14 | int:SRPK2 |
| Interaction | SNRPC interactions | GIGYF2 TFIP11 SRSF10 RBMXL1 SPEN RBBP6 BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 3.59e-12 | 440 | 34 | 12 | int:SNRPC |
| Interaction | SMC5 interactions | GIGYF2 DDX3Y PPHLN1 TFIP11 TIMELESS SRSF10 SRSF6 SPEN RBBP6 BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 | 1.88e-11 | 1000 | 34 | 15 | int:SMC5 |
| Interaction | RBMX interactions | TFIP11 SRSF10 RBMXL2 SRSF6 RBMXL1 RBMX DDX3X EIF4B DDX5 YLPM1 NCOA5 | 1.42e-10 | 461 | 34 | 11 | int:RBMX |
| Interaction | KIF20A interactions | GIGYF2 PPHLN1 TFIP11 SRSF10 RBMXL2 SRSF6 PPP1R13L RBMXL1 RBBP6 BCLAF1 RBMX DDX5 YLPM1 SMTN | 5.34e-10 | 1052 | 34 | 14 | int:KIF20A |
| Interaction | MECP2 interactions | DDX3Y TFIP11 SRSF10 SRSF6 RBMXL1 SPEN USP42 RBBP6 DROSHA BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 6.47e-10 | 1287 | 34 | 15 | int:MECP2 |
| Interaction | SNRNP40 interactions | TFIP11 SRSF10 SRSF6 ZBTB11 SPEN USP42 RBBP6 BCLAF1 RBMX DDX5 NCOA5 | 4.26e-09 | 637 | 34 | 11 | int:SNRNP40 |
| Interaction | SNRPA interactions | PPHLN1 TFIP11 SRSF10 RBBP6 BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 4.37e-09 | 482 | 34 | 10 | int:SNRPA |
| Interaction | SRSF6 interactions | PPHLN1 SRSF10 SRSF6 ZBTB11 RBMXL1 SPEN RBBP6 BCLAF1 RBMX NCOA5 | 6.57e-09 | 503 | 34 | 10 | int:SRSF6 |
| Interaction | DHX40 interactions | 6.68e-09 | 249 | 34 | 8 | int:DHX40 | |
| Interaction | CPSF6 interactions | PPHLN1 SRSF10 SRSF6 RBBP6 BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 1.01e-08 | 526 | 34 | 10 | int:CPSF6 |
| Interaction | PPP1CC interactions | PPHLN1 SRSF10 SRSF6 PPP1R13L RBMXL1 BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 1.95e-08 | 738 | 34 | 11 | int:PPP1CC |
| Interaction | HNRNPA1 interactions | PPHLN1 TFIP11 SRSF10 SRSF6 DROSHA BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 NCOA5 | 2.22e-08 | 945 | 34 | 12 | int:HNRNPA1 |
| Interaction | PRC1 interactions | TFIP11 SRSF10 RBMXL2 SRSF6 PPP1R13L RBMXL1 SPEN RBBP6 BCLAF1 RBMX DDX5 NCOA5 | 3.07e-08 | 973 | 34 | 12 | int:PRC1 |
| Interaction | CLK2 interactions | 3.07e-08 | 195 | 34 | 7 | int:CLK2 | |
| Interaction | MEN1 interactions | GIGYF2 PPHLN1 TFIP11 SRSF10 SRSF6 SPEN RBBP6 DROSHA BCLAF1 RBMX DDX5 YLPM1 | 5.68e-08 | 1029 | 34 | 12 | int:MEN1 |
| Interaction | RBM39 interactions | PPHLN1 TFIP11 SRSF10 SRSF6 DROSHA BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 NCOA5 | 6.52e-08 | 1042 | 34 | 12 | int:RBM39 |
| Interaction | CLK1 interactions | 6.82e-08 | 219 | 34 | 7 | int:CLK1 | |
| Interaction | CLK3 interactions | 7.03e-08 | 220 | 34 | 7 | int:CLK3 | |
| Interaction | ZC3H18 interactions | PPHLN1 TFIP11 SRSF10 SRSF6 RBMXL1 SPEN RBBP6 BCLAF1 RBMX DDX5 NCOA5 | 1.14e-07 | 877 | 34 | 11 | int:ZC3H18 |
| Interaction | SSRP1 interactions | PPHLN1 TIMELESS SRSF6 RBBP6 DROSHA BCLAF1 RBMX DDX5 YLPM1 NCOA5 | 1.21e-07 | 685 | 34 | 10 | int:SSRP1 |
| Interaction | RNF113A interactions | GIGYF2 SRSF6 PPP1R13L ZBTB11 RBBP6 BCLAF1 DDX3X EIF4B DDX5 YLPM1 | 1.33e-07 | 692 | 34 | 10 | int:RNF113A |
| Interaction | SRSF3 interactions | 1.44e-07 | 522 | 34 | 9 | int:SRSF3 | |
| Interaction | CHD4 interactions | GIGYF2 TFIP11 SRSF6 SPEN RBBP6 BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 2.24e-07 | 938 | 34 | 11 | int:CHD4 |
| Interaction | TNIP2 interactions | GIGYF2 TFIP11 SRSF6 PPP1R13L RBBP6 BCLAF1 RBMX DDX3X EIF4B DDX5 YLPM1 | 2.59e-07 | 952 | 34 | 11 | int:TNIP2 |
| Interaction | EED interactions | PPHLN1 TFIP11 SRSF10 SRSF6 SPEN RBBP6 DROSHA BCLAF1 RBMX DDX3X DDX5 YLPM1 NCOA5 | 2.80e-07 | 1445 | 34 | 13 | int:EED |
| Interaction | HNRNPCL2 interactions | 3.13e-07 | 274 | 34 | 7 | int:HNRNPCL2 | |
| Interaction | MCM5 interactions | 3.76e-07 | 420 | 34 | 8 | int:MCM5 | |
| Interaction | SRSF7 interactions | 4.11e-07 | 425 | 34 | 8 | int:SRSF7 | |
| Interaction | DHX8 interactions | 4.80e-07 | 292 | 34 | 7 | int:DHX8 | |
| Interaction | LINC02910 interactions | 5.23e-07 | 95 | 34 | 5 | int:LINC02910 | |
| Interaction | DOT1L interactions | GIGYF2 PPHLN1 TFIP11 SRSF10 SRSF6 RBBP6 DROSHA DDX3X DDX5 NCOA5 | 5.48e-07 | 807 | 34 | 10 | int:DOT1L |
| Interaction | THRAP3 interactions | 5.63e-07 | 443 | 34 | 8 | int:THRAP3 | |
| Interaction | SRSF4 interactions | 5.76e-07 | 300 | 34 | 7 | int:SRSF4 | |
| Interaction | LUZP4 interactions | 6.42e-07 | 99 | 34 | 5 | int:LUZP4 | |
| Interaction | NUP43 interactions | 6.56e-07 | 625 | 34 | 9 | int:NUP43 | |
| Interaction | TRIM31 interactions | 6.77e-07 | 454 | 34 | 8 | int:TRIM31 | |
| Interaction | PPP1CB interactions | 8.65e-07 | 469 | 34 | 8 | int:PPP1CB | |
| Interaction | U2AF2 interactions | 9.22e-07 | 651 | 34 | 9 | int:U2AF2 | |
| Interaction | MATR3 interactions | 9.70e-07 | 655 | 34 | 9 | int:MATR3 | |
| Interaction | BMI1 interactions | 1.02e-06 | 659 | 34 | 9 | int:BMI1 | |
| Interaction | BCLAF1 interactions | 1.03e-06 | 327 | 34 | 7 | int:BCLAF1 | |
| Interaction | DDX23 interactions | 1.03e-06 | 480 | 34 | 8 | int:DDX23 | |
| Interaction | YAP1 interactions | GIGYF2 TFIP11 SRSF6 SPEN RBBP6 DROSHA BCLAF1 DDX3X EIF4B DDX5 YLPM1 | 1.04e-06 | 1095 | 34 | 11 | int:YAP1 |
| Interaction | MYCN interactions | PPHLN1 TFIP11 POLR2M SRSF10 SRSF6 RBMXL1 RBBP6 MARK3 BCLAF1 RBMX DDX3X DDX5 | 1.28e-06 | 1373 | 34 | 12 | int:MYCN |
| Interaction | CHMP4C interactions | 1.44e-06 | 687 | 34 | 9 | int:CHMP4C | |
| Interaction | FBP1 interactions | 1.55e-06 | 348 | 34 | 7 | int:FBP1 | |
| Interaction | CMTR1 interactions | 1.56e-06 | 218 | 34 | 6 | int:CMTR1 | |
| Interaction | SNRPB interactions | 1.79e-06 | 517 | 34 | 8 | int:SNRPB | |
| Interaction | SRSF9 interactions | 1.83e-06 | 224 | 34 | 6 | int:SRSF9 | |
| Interaction | MTF1 interactions | 1.88e-06 | 123 | 34 | 5 | int:MTF1 | |
| Interaction | CUL4B interactions | 2.32e-06 | 728 | 34 | 9 | int:CUL4B | |
| Interaction | LARP4B interactions | 2.73e-06 | 240 | 34 | 6 | int:LARP4B | |
| Interaction | SNRNP70 interactions | PPHLN1 TFIP11 SRSF10 SRSF6 RBMXL1 RBBP6 BCLAF1 RBMX DDX3X DDX5 | 3.30e-06 | 984 | 34 | 10 | int:SNRNP70 |
| Interaction | PAGE4 interactions | 3.70e-06 | 253 | 34 | 6 | int:PAGE4 | |
| Interaction | PABPC5 interactions | 3.82e-06 | 142 | 34 | 5 | int:PABPC5 | |
| Interaction | APOBEC3D interactions | 4.68e-06 | 148 | 34 | 5 | int:APOBEC3D | |
| Interaction | MAGOH interactions | 4.72e-06 | 264 | 34 | 6 | int:MAGOH | |
| Interaction | RBMXL1 interactions | 5.86e-06 | 155 | 34 | 5 | int:RBMXL1 | |
| Interaction | DDX17 interactions | 5.90e-06 | 426 | 34 | 7 | int:DDX17 | |
| Interaction | WWP2 interactions | 7.45e-06 | 840 | 34 | 9 | int:WWP2 | |
| Interaction | CUL7 interactions | 7.82e-06 | 845 | 34 | 9 | int:CUL7 | |
| Interaction | HNRNPC interactions | 8.08e-06 | 634 | 34 | 8 | int:HNRNPC | |
| Interaction | NDN interactions | 8.81e-06 | 453 | 34 | 7 | int:NDN | |
| Interaction | EIF3F interactions | 9.08e-06 | 296 | 34 | 6 | int:EIF3F | |
| Interaction | DYRK2 interactions | 1.00e-05 | 173 | 34 | 5 | int:DYRK2 | |
| Interaction | SRRM2 interactions | 1.00e-05 | 462 | 34 | 7 | int:SRRM2 | |
| Interaction | PNN interactions | 1.02e-05 | 302 | 34 | 6 | int:PNN | |
| Interaction | RC3H2 interactions | 1.17e-05 | 667 | 34 | 8 | int:RC3H2 | |
| Interaction | H19 interactions | 1.25e-05 | 27 | 34 | 3 | int:H19 | |
| Interaction | OBSL1 interactions | 1.32e-05 | 902 | 34 | 9 | int:OBSL1 | |
| Interaction | ELAVL2 interactions | 1.50e-05 | 188 | 34 | 5 | int:ELAVL2 | |
| Interaction | CIT interactions | DDX3Y TFIP11 SRSF10 RBMXL2 SRSF6 RBMXL1 RBBP6 BCLAF1 RBMX DDX5 NCOA5 | 1.57e-05 | 1450 | 34 | 11 | int:CIT |
| Interaction | EIF4A3 interactions | 1.65e-05 | 499 | 34 | 7 | int:EIF4A3 | |
| Interaction | PRMT1 interactions | 1.67e-05 | 929 | 34 | 9 | int:PRMT1 | |
| Interaction | TNIP1 interactions | 2.15e-05 | 1217 | 34 | 10 | int:TNIP1 | |
| Interaction | PYHIN1 interactions | 2.66e-05 | 358 | 34 | 6 | int:PYHIN1 | |
| Interaction | ZC3H11A interactions | 2.85e-05 | 215 | 34 | 5 | int:ZC3H11A | |
| Interaction | FUS interactions | 2.91e-05 | 757 | 34 | 8 | int:FUS | |
| Interaction | CHD3 interactions | 2.91e-05 | 757 | 34 | 8 | int:CHD3 | |
| Interaction | HNRNPDL interactions | 2.92e-05 | 364 | 34 | 6 | int:HNRNPDL | |
| Interaction | SP1 interactions | 2.97e-05 | 365 | 34 | 6 | int:SP1 | |
| Interaction | RBM14 interactions | 3.19e-05 | 553 | 34 | 7 | int:RBM14 | |
| Interaction | ANKRD50 interactions | 3.20e-05 | 108 | 34 | 4 | int:ANKRD50 | |
| Interaction | KHDRBS1 interactions | 3.35e-05 | 373 | 34 | 6 | int:KHDRBS1 | |
| Interaction | SFPQ interactions | 3.57e-05 | 563 | 34 | 7 | int:SFPQ | |
| Interaction | KIF23 interactions | 3.81e-05 | 1031 | 34 | 9 | int:KIF23 | |
| Interaction | CD2BP2 interactions | 4.10e-05 | 232 | 34 | 5 | int:CD2BP2 | |
| Interaction | RBMXL2 interactions | 4.15e-05 | 40 | 34 | 3 | int:RBMXL2 | |
| Interaction | NCOA5 interactions | 4.99e-05 | 121 | 34 | 4 | int:NCOA5 | |
| Interaction | NXF1 interactions | CRY2 PPHLN1 TFIP11 ZBTB11 DROSHA BCLAF1 RBMX DDX5 YLPM1 NCOA5 | 5.06e-05 | 1345 | 34 | 10 | int:NXF1 |
| Interaction | EIF4B interactions | 5.09e-05 | 402 | 34 | 6 | int:EIF4B | |
| Interaction | TAF15 interactions | 5.52e-05 | 408 | 34 | 6 | int:TAF15 | |
| Interaction | CLK4 interactions | 5.54e-05 | 44 | 34 | 3 | int:CLK4 | |
| Interaction | RBM7 interactions | 5.84e-05 | 126 | 34 | 4 | int:RBM7 | |
| Interaction | ANAPC15 interactions | 6.21e-05 | 128 | 34 | 4 | int:ANAPC15 | |
| Interaction | HNRNPK interactions | 6.79e-05 | 853 | 34 | 8 | int:HNRNPK | |
| Interaction | KCNA3 interactions | 7.86e-05 | 871 | 34 | 8 | int:KCNA3 | |
| Interaction | SF3A2 interactions | 8.87e-05 | 273 | 34 | 5 | int:SF3A2 | |
| Interaction | ECT2 interactions | 8.93e-05 | 887 | 34 | 8 | int:ECT2 | |
| GeneFamily | RNA binding motif containing | 8.33e-09 | 213 | 24 | 7 | 725 | |
| GeneFamily | DEAD-box helicases | 2.28e-05 | 42 | 24 | 3 | 499 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.11e-04 | 12 | 24 | 2 | 737 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 6.84e-08 | 166 | 34 | 6 | M8129 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DDX3Y PPHLN1 SRSF10 SPEN USP42 RBBP6 MARK3 BCLAF1 DDX3X EIF4B DDX5 | 1.66e-06 | 1492 | 34 | 11 | M40023 |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 4.01e-06 | 186 | 34 | 5 | M4911 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 5.58e-06 | 199 | 34 | 5 | M5564 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 2.24e-05 | 680 | 34 | 7 | M41089 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 2.97e-05 | 474 | 34 | 6 | M40991 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 5.19e-05 | 1394 | 34 | 9 | M9585 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 6.00e-05 | 794 | 34 | 7 | MM982 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN | 1.25e-04 | 199 | 34 | 4 | M7659 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN | 1.28e-04 | 200 | 34 | 4 | M7134 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 1.61e-04 | 644 | 34 | 6 | M41717 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 2.28e-04 | 687 | 34 | 6 | M41022 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 2.81e-04 | 714 | 34 | 6 | M1744 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.99e-04 | 250 | 34 | 4 | M11318 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 3.14e-04 | 102 | 34 | 3 | M2124 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.19e-04 | 467 | 34 | 5 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.76e-04 | 484 | 34 | 5 | MM999 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL | 4.12e-04 | 272 | 34 | 4 | M41669 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 4.37e-04 | 776 | 34 | 6 | M1107 | |
| Coexpression | AZARE_STAT3_TARGETS | 4.43e-04 | 24 | 34 | 2 | M2312 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 4.46e-04 | 115 | 34 | 3 | M7995 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 4.65e-04 | 281 | 34 | 4 | M4077 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.59e-05 | 564 | 34 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.84e-07 | 197 | 34 | 5 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.14e-07 | 200 | 34 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.35e-06 | 135 | 34 | 4 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.24e-05 | 188 | 34 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 1.52e-05 | 198 | 34 | 4 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 1.52e-05 | 198 | 34 | 4 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.55e-05 | 199 | 34 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Sigmoid-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 1.58e-05 | 200 | 34 | 4 | 9c21e6b8d4f8e526950adacf9cc45a5e86d81c1f | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.58e-05 | 200 | 34 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.58e-05 | 200 | 34 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 2.96e-04 | 171 | 34 | 3 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.27e-04 | 177 | 34 | 3 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 178 | 34 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.67e-04 | 184 | 34 | 3 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-04 | 186 | 34 | 3 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 190 | 34 | 3 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 191 | 34 | 3 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | ced2fdbcb181ac250ff50cd4d5d886e568924203 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 4.15e-04 | 192 | 34 | 3 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | 19b8675ed8a99bd3d08ad043e4ec9f006426c22f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.22e-04 | 193 | 34 | 3 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 195 | 34 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.48e-04 | 197 | 34 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 4.48e-04 | 197 | 34 | 3 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-04 | 198 | 34 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 198 | 34 | 3 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | (1)_T_cell-(11)_Activated_CD4_T|(1)_T_cell / shred on Cell_type and subtype | 4.54e-04 | 198 | 34 | 3 | 4b9ad91342f622c63e476d4f6a0ae5bf282a7ef5 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-04 | 198 | 34 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 198 | 34 | 3 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 198 | 34 | 3 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 4.61e-04 | 199 | 34 | 3 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.61e-04 | 199 | 34 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 199 | 34 | 3 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.61e-04 | 199 | 34 | 3 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 4.61e-04 | 199 | 34 | 3 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 4.68e-04 | 200 | 34 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Computational | Neighborhood of HDAC1 | 1.30e-04 | 110 | 26 | 4 | GNF2_HDAC1 | |
| Computational | Genes in the cancer module 32. | 2.43e-04 | 241 | 26 | 5 | MODULE_32 | |
| Computational | Neighborhood of FBL | 3.87e-04 | 146 | 26 | 4 | GNF2_FBL | |
| Computational | Neighborhood of DDX5 | 4.53e-04 | 63 | 26 | 3 | GNF2_DDX5 | |
| Computational | Neighborhood of RBBP6 | 6.18e-04 | 70 | 26 | 3 | GNF2_RBBP6 | |
| Disease | childhood medulloblastoma (implicated_via_orthology) | 1.21e-06 | 2 | 33 | 2 | DOID:3869 (implicated_via_orthology) | |
| Disease | Sertoli cell-only syndrome (implicated_via_orthology) | 7.27e-06 | 4 | 33 | 2 | DOID:0050457 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.14e-04 | 702 | 33 | 6 | C0009402 | |
| Disease | response to corticosteroid | 4.83e-04 | 29 | 33 | 2 | GO_0031960 | |
| Disease | cortical thickness | 1.31e-03 | 1113 | 33 | 6 | EFO_0004840 | |
| Disease | aortic measurement | 2.75e-03 | 251 | 33 | 3 | EFO_0020865 | |
| Disease | Mental Depression | 2.84e-03 | 254 | 33 | 3 | C0011570 | |
| Disease | brain measurement, neuroimaging measurement | 3.18e-03 | 550 | 33 | 4 | EFO_0004346, EFO_0004464 | |
| Disease | Depressive disorder | 4.08e-03 | 289 | 33 | 3 | C0011581 | |
| Disease | beta-amyloid 1-42 measurement | 4.28e-03 | 87 | 33 | 2 | EFO_0004670 | |
| Disease | physical activity | 4.37e-03 | 88 | 33 | 2 | EFO_0003940 | |
| Disease | Neurodevelopmental Disorders | 4.87e-03 | 93 | 33 | 2 | C1535926 | |
| Disease | S-7-hydroxywarfarin measurement | 6.74e-03 | 110 | 33 | 2 | EFO_0803329 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESTRSYRRGARSPED | 851 | Q8TDY4 | |
| SPRGYRRRRADGASS | 961 | Q8TER5 | |
| PSRGRREDRGFSYRS | 3076 | Q7Z408 | |
| QPGDGERRYREASAR | 341 | Q8WXI4 | |
| LRFDEYGSSGRPRRS | 271 | Q8TE60 | |
| SRDDYPSRGYSDRDG | 251 | P38159 | |
| PSRGYSDRDGYGRDR | 256 | P38159 | |
| GSRGRFDDRGRSDYD | 91 | O00571 | |
| DDRRDRYSAGKRGGF | 491 | P17844 | |
| TRRDPYGFGDSRDSR | 11 | Q9HCD5 | |
| YGFGDSRDSRRDRSP | 16 | Q9HCD5 | |
| RNSPFTRGRREDYVG | 871 | Q7Z6E9 | |
| RGYRRVRSGSGSIDD | 266 | Q6Y7W6 | |
| GFGRRTDPSGDYIRR | 436 | Q49AN0 | |
| PRDESRGRSSFYPDG | 311 | Q9NYF8 | |
| PTEYERNGRYEGSSR | 626 | P27448 | |
| SRGRFDDRGRSDYDG | 91 | O15523 | |
| RSYNPEGESSGRYRE | 341 | P0CAP2 | |
| SPLASDRRSDAGSYR | 316 | Q8WUF5 | |
| YDEGRSFSHDRRSGP | 61 | Q8NEY8 | |
| RGSRDYDRGYDSRIG | 261 | P23588 | |
| SGRRAFGSGYRRDDD | 276 | P23588 | |
| QDSRYRSDYDRGRTP | 261 | Q9NRR4 | |
| PSRGYGDRDGYGRDR | 256 | Q96E39 | |
| RGPRRDRDGYSYGSR | 71 | Q13247 | |
| RGYRDDRSPAREPGD | 186 | B3KU38 | |
| SRDGYSSRDYREPRG | 216 | O75526 | |
| GDYAREGGRFFPRER | 251 | O75969 | |
| GYGSLDDRSSSRRAP | 806 | Q9UNS1 | |
| GHYRSRRERSSSGEP | 951 | Q9H9J4 | |
| FGPDDDTYRSRLRQR | 496 | O95625 | |
| TYPEDSRRDYPARGR | 641 | Q96T58 | |
| SRRDYPARGREFYSE | 646 | Q96T58 | |
| TRSEDLRREFGRYGP | 21 | O75494 | |
| SRRGGFDRPSYDRKS | 1756 | P49750 | |
| GSEGSRERFRGFRYP | 41 | Q9BRR0 | |
| RLYSGRPNSGSREDS | 131 | P53814 | |
| DERPSFGGKRARDYS | 61 | Q9UBB9 |